TNF and inflammatory bowel disease: To control for covariates, we applied a linear mixed model (LMM) analysis, which reveals significant separation of active and EH samples from non-IBD samples (p.adj < 0.0001, p.adj = 0.003) but no separation by location or anti-TNF treatment (p.adj > 0.8).